Reaction
Bronchostenosis reporting signals
As of the last recalculation, Bronchostenosis appears in 545 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 48.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 15 | 48.3 | 48.3 |
| Amphotericin B | 12 | 37.4 | 37.4 |
| Cefazolin | 8 | 34.0 | 34.0 |
| Valganciclovir | 16 | 33.4 | 33.4 |
| Valganciclovir Hydrochloride | 16 | 33.4 | 33.4 |
| Pemetrexed | 16 | 29.3 | 29.4 |
| Cefazolin Sodium | 8 | 25.7 | 25.7 |
| Pemetrexed Disodium | 22 | 22.9 | 23.0 |
| Erlotinib | 5 | 19.9 | 19.9 |
| Rocuronium Bromide | 5 | 16.3 | 16.4 |
| Erlotinib Hydrochloride | 5 | 15.4 | 15.4 |
| Crizotinib | 5 | 15.2 | 15.2 |